The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.
Open accessAbstract
The gene encoding cytosine deaminase (CD) has been expressed in the human colorectal carcinoma cell line WiDr. Metabolism studies confirm that tumor cells expressing CD convert the very nontoxic prodrug 5-fluorocytosine (5FCyt) to 5-fluorouracil (5FUra) and 5FUra metabolites. Tumor xenografts composed of CD-expressing cells can selectively generate tumor levels of > 400 microM 5FUra when the host mouse is dosed with nontoxic levels of 5FCyt. The selective metabolic conversion of 5FCyt to 5FUra in CD-expressing tumor cells results in the inhibition of thymidylate synthase and incorporation of 5FUra into RNA. 5FUra is also liberated into the surrounding environment when CD-expressing tumor cells are treated with 5FCyt. The liberated 5FUra is able to kill neighboring, non-CD-expressing tumor cells in vitro and in vivo. Most importantly, when only 2% of the tumor mass contains CD-expressing cells (98% non-CD-expressing cells), significant regressions in all tumors are observed when the host mouse is dosed with nontoxic levels of 5FCyt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., & Blaese, R. M. (1992) · Science · doi:10.1126/science.1317968 · Cited by 1,509
Poon, M. A., O'Connell, M. J., Moertel, C. G., Wieand, H. S., Cullinan, S. A., Everson, L. K., Krook, J. E., Mailliard, J. A., Laurie, J. A., & Tschetter, L. K. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1407 · Cited by 887
Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transfered by Retroviral Vectors
Moolten, F. L., & Wells, J. M. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.4.297 · Cited by 507
Mullen, C. A., Kilstrup, M., & Blaese, R. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.33 · Cited by 497
α-Fetoprotein in Cancer and Fetal Development
(1979) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60849-0 · Cited by 296
Prostate-specific antigen: biochemistry, analytical methods, and clinical application
Armbruster, D. A. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.2.181 · Cited by 285
Targeting of an inducible toxic phenotype in animal cells.
Borrelli, E., Heyman, R., Hsi, M., & Evans, R. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7572 · Cited by 244
Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C., Tibbels, S., & Richards, C. A. (1993) · PubMed · Cited by 228
Self-citationBaley, J. E., Meyers, C., Kliegman, R. M., Jacobs, M. R., & Blumer, J. L. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82674-5 · Cited by 184
Austin, E. A., & Huber, B. E. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13624-9 · Cited by 166
Self-citationKoechlin, B. A., Rubio, F., Palmer, S., Gabriel, T. F., & Duschinsky, R. (1966) · Biochemical Pharmacology · doi:10.1016/0006-2952(66)90254-1 · Cited by 131
Diasio, R. B., Lakings, D. E., & Bennett, J. E. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.6.903 · Cited by 128
Danielsen, S., Kilstrup, M., Barilla, K. C., Jochimsen, B. U., & Neuhard, J. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb00854.x · Cited by 122
Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators
Weckbecker, G. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90051-m · Cited by 96
High affinity sodium-dependent nucleobase transport in cultured renal epithelial cells (LLC-PK1).
Griffith, D. A., & Jarvis, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80697-8 · Cited by 49
Richards, C. A., Wolberg, A. S., & Huber, B. E. (1993) · DNA sequence · doi:10.3109/10425179309015631 · Cited by 15
Self-citation
Cited by
Aboody, K. S., Brown, A., Rainov, N. G., Bower, K. A., Liu, S., Yang, W., Small, J. E., Herrlinger, U., Ourednik, V., Black, P. M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12846 · Cited by 1,207
Rainov, N. G. (2000) · Human Gene Therapy · doi:10.1089/104303400750038499 · Cited by 698
Purine nucleoside phosphorylases: properties, functions, and clinical aspects
Bzowska, A., Kulikowska, E., & Shugar, D. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00097-8 · Cited by 495
Prodrugs for improving tumor targetability and efficiency
Mahato, R., Tai, W., & Cheng, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.002 · Cited by 353
Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
Mizrak, A., Bolukbasi, M. F., Ozdener, G. B., Brenner, G. J., Madlener, S., Erkan, E. P., Ströbel, T., Breakefield, X. O., & Saydam, O. (2013) · Molecular Therapy · doi:10.1038/mt.2012.161 · Cited by 337
Metadata
- Authors
- Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., & Good, S. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-08-16
- Volume
- 91
- Issue
- 17
- Pages
- 8302-8306
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2017593380
- Cited by
- 420
- References
- 16
- FWCI
- 21.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.